Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03425513 |
Date of registration:
|
01/02/2018 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Hepatitis B Virus Prevalence and Risk Factors in Belgium
HBVBE |
Scientific title:
|
Hepatitis B Virus Prevalence and Risk Factors in Middle Limburg Belgium: the Importance of Migration. |
Date of first enrolment:
|
May 12, 2017 |
Target sample size:
|
1131 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03425513 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Belgium
| | | | | | | |
Contacts
|
Name:
|
Geert Robaeys, M.D., Ph.D. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hasselt University |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age between 18 and 70
- Males and females
Exclusion Criteria:
/
Age minimum:
18 Years
Age maximum:
70 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Hepatitis B
|
Intervention(s)
|
Diagnostic Test: Hepatitis B serology
|
Other: Questionnaire
|
Primary Outcome(s)
|
Seroprevalence of past or current HBV infection in the Middle Limburg population
[Time Frame: 1 day]
|
Seroprevalence of current HBV infection in the Middle Limburg population
[Time Frame: 1 day]
|
Secondary Outcome(s)
|
Assess risk factors for past or current HBV infection in the Middle Limburg population
[Time Frame: 1 day]
|
Assess risk factors for current HBV infection in the Middle Limburg population
[Time Frame: 1 day]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|